Significance of factor V, prothrombin, MTHFR, and PAI-1 genotypes in childhood cerebral thrombosis

Clinical and Applied Thrombosis/Hemostasis

Volumn 13, Issue 2, 2007, Pages 154-160

  Ozyurek, Emel ^a   Balta, Gunay ^a   Degerliyurt, Aydan ^a   Parlak, Hülya ^a   Aysun, Sabiha ^a   Gürgey, Aytemiz ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Cerebral thrombosis; Childhood; Genetic risk factors

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTHROMBIN;

ADOLESCENT; ARTICLE; CHILD; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC ANALYSIS; GENETIC RISK; GENOTYPE; HETEROZYGOSITY; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; OCCLUSIVE CEREBROVASCULAR DISEASE; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; TURKEY (REPUBLIC);

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FACTOR V; FEMALE; GENOTYPE; HUMANS; INFANT; INFANT, NEWBORN; INTRACRANIAL THROMBOSIS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MUTATION; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTHROMBIN; RISK FACTORS;

EID: 34047244001     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/1076029606298988     Document Type: Article

References (26)

1. Riela AR, Roach ES Etiology of stroke in children. J Child Neurol 1993 ; 8: 201.
2. Akar N., Akar E., Deda G. Coexistence of two prothrombotic mutations, factor V 1691 G-A and prothrombin gene 20210 G-A, and the risk of cerebral infarct in pediatric patients. Pediatr Hematol Oncol 1999 ; 16: 565.
3. Kenet G., Sadetzki S., Murad H., et al. Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children. Stroke 2000 ; 31: 1283.
4. Nowak-Gottl U., Strater R., Heinecke A., et al, for Childhood Stroke Study Group. Lipoprotein (a) and genetic polymorphism of clotting factor V, prothrombin, and methylenetetrahydrofolate reductase are risk factors of spontaneous ischemic stroke in childhood. Blood 1999 ; 94: 3678.
5. Zenz W., Bodó Z., Plotho J., et al. Factor V Leiden and prothrombin gene G20210A variant in children with ischemic stroke. Thromb Haemost 1998 ; 80: 763.
6. Bonduel M., Sciuccati G., Hepner M., et al. Factor V Leiden and prothrombin G20210A mutation in children with cerebral thromboembolism. Am J Hematol 2003 ; 73: 81.
7. Ganesan V., Prengler M., McShane MA, et al. Investigation of risk factors in children with arterial ischemic stroke. Ann Neurol 2003 ; 53: 167.
8. McColl MD, Chalmers EA, Thomas A., et al. Factor V Leiden, prothrombin 20210 G∅A and the MTHFR C677T mutations in childhood stroke. Thromb Haemost 1999 ; 81: 690.
9. Akar N., Akar E., Deda G., et al. Factor V1691 G-A, prothrombin 20210 G-A, and methylenetetrahydrofolate reductase 677 C-T variants in Turkish children with cerebral infarct. J Child Neurol 1999 ; 14: 749.
10. Prengler M., Sturt N., Krywawych S., et al. Homozygous thermolabile variant of the methylenetetrahydrofolate reductase gene: A potential risk factor for hyperhomocysteinemia, CVD, and stroke in childhood. Dev Med Child Neurol 2001 ; 43: 220.
11. Cardo E., Monros E., Colome C., et al. Children with stroke: Polymorphism of the MTHFR gene, mild hyperhomocysteinemia, and vitamin status. J Child Neurol 2000 ; 15: 295.
12. Akar N., Akar E., Ylmaz E., Deda G. Plasminogen activator inhibitor-1 4G/5G polymorphism in Turkish children with cerebral infarct and effect on factor V 1691 A mutation. J Child Neurol 2001 ; 16: 294.
13. Nowak-Gottl U., Strater R., Kosch A., et al. The plasminogen activator inhibitor (PAI)-1 promoter 4G/4G genotype is not associated with ischemic stroke in a population of German children. Childhood Stroke Study Group. Eur J Haematol 2001 ; 66: 57.
14. Vielhaber H., Ehrenforth S., Koch HG, et al. Cerebral venous sinus thrombosis in infancy and childhood: Role of genetic and acquired risk factors of thrombophilia. Eur J Pediatr 1998 ; 157: 555.
15. DeVeber G., Andrew M., Adams C., et al, for the Canadian Pediatric Ischemic Stroke Study Group. Cerebral sinovenous thrombosis in children. N Engl J Med 2001 ; 345: 417.
16. Gurgey A., Mesci L. The prevalence of factor V Leiden (1691 G-A) mutation in Turkey. Turk J Pediatr 1997 ; 39: 313.
17. Gurgey A., Hicsonmez G., Parlak H., et al. The prothrombin gene 20210 G-A mutation in Turkish patients with thrombosis. Am J Hematol 1998 ; 59: 179.
18. Balta G., Yuksek N., Ozyurek E., et al. Characterization of MTHFR, GSTM1, GSTT1, GSTP1, CYPA1 genotypes in childhood leukemia. Am J Hematol 2003 ; 73: 154.
19. Balta G., Altay C., Gurgey A. PAI-1 gene 4G/5G genotype: A risk factor for thrombosis in vessels of internal organs. Am J Hematol 2002 ; 71: 89.
20. Bertina RM, Koeleman Bpc, Koster T., et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994 ; 369: 64.
21. Poort SR, Rosendaal FR, Reistma PH, Bertina RM A common genetic variation in the 3-prime-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996 ; 88: 3698.
22. Frosst P., Blom HJ, Milos R., et al. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995 ; 10: 111.
23. Doggen Cjm, Bertina RM, Manger Cats V., et al. The 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene is not associated with myocardial infarction. Thromb Haemost 1999 ; 82: 115.
24. deVeber G., Monagle P., Chan A., et al. Prothrombotic disorders in infants and children with cerebral thromboembolism. Arch Neurol 1998 ; 55: 1539.
25. Lynch JK, Nelson KB, Curry CJ, Grether JK Cerebrovascular disorders in children with the factor V Leiden mutation. J Child Neurol 2001 ; 16: 735.
26. Gurgey A. Clinical manifestations in thrombotic children with factor V Leiden mutation. Pediatr Hematol Oncol 1999 ; 16: 233.